Jun Ishigohoka15 июл., 22:37www.science.org/doi/10.1126/...CD4+ T cells reactive to Epstein-Barr virus late lytic antigens are enriched in individuals with multiple sclerosisCD4+ T cells in MS preferentially recognize EBV viral particles rather than latent antigens, and responses are reduced by B cell–targeting therapies.www.science.org